Center-Authored Papers

Filters: Author is Rutter, Carolyn M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Tosteson ANA, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose PV, Wheeler CM, Barlow WE, Bronson M et al..  2016.  Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.. Journal of general internal medicine. 31(4):372-379. Abstract
Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA et al..  2014.  The CRC screening process in community settings: A conceptual model for the Population-based Research Optimizing Screening through Personalized Regimens Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
P
Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Potter JD, Upton MP, Zhu L-C, Rosenfeld ME, Schwartz SM, Rutter CM.  2015.  Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.. Cancer causes & control : CCC. 26(3):467-73. Abstract
M
McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF et al..  2016.  Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.. American journal of preventive medicine. 51(4):507-512. Abstract
L
Lehman CD, Rutter CM, Eby PR, White E, Buist DSM, Taplin SH.  2008.  Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography.. AJR. American journal of roentgenology. 190(2):511-5. Abstract
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EAM, Pabiniak C, van Ballegooijen M et al..  2014.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.. Annals of internal medicine. 161(2):104-12. Abstract
K
Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A et al..  2016.  Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.. American journal of preventive medicine. 51(3):e67-75. Abstract
H
Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA.  2016.  Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.. Journal of general internal medicine. Abstract
D
Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DSM, Ash AS, Rutter CM, Doria-Rose PV, Corley DA, Greenlee RT et al..  2013.  Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.. Annals of internal medicine. 158(5 Pt 1):312-20. Abstract
C
Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A et al..  2016.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose PV, Doubeni CA, Buist DSM.  2013.  Measurement in comparative effectiveness research.. American journal of preventive medicine. 44(5):513-9. Abstract